Moed, H., Stoof, T., Boorsma, D., von Blomberg, B., Gibbs, S., Bruynzeel, D., . . . Rustemeyer, T. (2004). Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2 T cell profiles. Clinical & Experimental Allergy, 34(12), 1868. https://doi.org/10.1111/j.1365-2222.2004.02124.x
Chicago Style (17th ed.) CitationMoed, H., T.J Stoof, D.M Boorsma, B.M.E von Blomberg, S. Gibbs, D.P Bruynzeel, R.J Scheper, and T. Rustemeyer. "Identification of Anti-inflammatory Drugs According to Their Capacity to Suppress Type-1 and Type-2 T Cell Profiles." Clinical & Experimental Allergy 34, no. 12 (2004): 1868. https://doi.org/10.1111/j.1365-2222.2004.02124.x.
MLA (9th ed.) CitationMoed, H., et al. "Identification of Anti-inflammatory Drugs According to Their Capacity to Suppress Type-1 and Type-2 T Cell Profiles." Clinical & Experimental Allergy, vol. 34, no. 12, 2004, p. 1868, https://doi.org/10.1111/j.1365-2222.2004.02124.x.